22.07.2009 Head-to-head trial demonstrates Viramune^®’s similar efficacy and more favourable effect on lipid profile compared to atazanavir/ritonavir For medical media, outside the US only 09.07.2009 Successful promissory note (Schuldschein) placement 06.07.2009 European Commission approves statement on lipid improvement for Viramune^® label For medical media, outside the US only 26.06.2009 Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin (pramipexole) formulation for the treatment of Parkinson`s disease For medical media, outside the US only 22.06.2009 Expedition to Mount Everest offers new insights into chronic disease For medical media, outside the US only 15.06.2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease 14.06.2009 New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events For medical media, outside the US only 10.06.2009 New data once more show high therapeutic benefits of Boehringer Ingelheim`s Mirapexin<sup>®</sup>/Sifrol<sup>®</sup> (pramipexole) once-daily extended release formulation, also in patients with advanced Parkinson`s disease For medical media, outside the US only 06.06.2009 New data from Boehringer Ingelheim`s ongoing linagliptin trial programme show promising safety and efficacy results For medical media, outside the US only 29.05.2009 Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer